{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:00:35Z","timestamp":1792677635417,"version":"4.5.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,7]]},"abstract":"<jats:p>Psoriasis is a chronic immune-mediated disease characterized by systemic inflammation. In recent years, the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV) were shown to be important indicators of inflammation. The aim of the present study is to investigate NLR, PLR, SII, SIRI, PIV together in patients with psoriasis. This retrospective case-control study encompassed seventy-one individuals diagnosed with psoriasis and seventy healthy controls who underwent evaluation at the Dermatology clinics of Aksaray University Training and Research Hospital from January 2022 to January 2023. Inflammatory process indicators such as NLR, PLR, SII, SIRI, PIV were computed for analysis. A notable discovery from our research was the indication of a direct relationship between SII and Psoriasis Area Severity Index (PASI) scores. A statistically significant difference was found between the 2 groups in terms of neutrophils, lymphocytes, monocytes, and platelets (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The area under the curve of the SII score for psoriasis was 0.611. The optimal cutoff value of SII to predict psoriasis activation was 442.7, with 55.7% sensitivity and 45.7% specificity (95% confidence interval 0.518\u20130.704, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.024). A positive correlation was observed between SII, PIV and PASI (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004, <jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.34; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.006, <jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.32 respectively).There was no statistically significant distinction observed in the PLR indices between the groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). The present study investigation demonstrates the potential utility of SII, SIRI, and PIV in assessing psoriasis patients. Moreover, the findings suggest that SII and PIV could function as an autonomous prognostic marker for individuals diagnosed with psoriasis.<\/jats:p>","DOI":"10.1097\/md.0000000000041715","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:52:32Z","timestamp":1743205952000},"page":"e41715","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Pan-immune inflammation value and systemic inflammatory index as a measure of systemic inflammation in patients with psoriasis: A retrospective study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3312-6630","authenticated-orcid":false,"given":"Seyma","family":"Basar Kilic","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Faculty of Medicine, Aksaray University, Aksaray, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-5077","authenticated-orcid":false,"given":"Huseyin","family":"Erdal","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Aksaray University, Aksaray, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 2","key":"R1-20250328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris.","volume":"23","author":"Pathirana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis.","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis.","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R4-20250328","doi-asserted-by":"crossref","first-page":"12793","DOI":"10.3390\/ijms222312793","article-title":"The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications.","volume":"22","author":"Singh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R5-20250328","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies.","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.3390\/ijms23084457","article-title":"Psoriasis and systemic inflammatory disorders.","volume":"23","author":"Tashiro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5114\/ada.2018.77767","article-title":"Thiol\/disulphide balance in patients with psoriasis.","volume":"37","author":"Aksoy","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"R8-20250328","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/bjd.12144","article-title":"Oxidative stress and psoriasis: the effect of antitumour necrosis factor-\u03b1 inhibitor treatment.","volume":"168","author":"Bacchetti","year":"2013","journal-title":"Br J Dermatol"},{"key":"R9-20250328","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/10815589231191966","article-title":"Thiol\/disulfide homeostasis as a new oxidative stress marker in patients with Fabry disease.","volume":"71","author":"Erdal","year":"2023","journal-title":"J Investig Med"},{"key":"R10-20250328","doi-asserted-by":"crossref","first-page":"3000605231202145","DOI":"10.1177\/03000605231202145","article-title":"Effect of mode of delivery on neonatal oxidative stress and dynamic thiol-disulfide homeostasis.","volume":"51","author":"Genc","year":"2023","journal-title":"J Int Med Res"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/labmed\/lmad010","article-title":"Oxidative stress levels and dynamic thiol-disulfide balance in preterm newborns with bronchopulmonary dysplasia.","volume":"54","author":"Demirtas","year":"2023","journal-title":"Lab Med"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12887-023-03936-z","article-title":"Association between thiol-disulfide hemostasis and transient tachypnea of the newborn in late-preterm and term infants.","volume":"23","author":"Demirtas","year":"2023","journal-title":"BMC Pediatr"},{"key":"R13-20250328","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4328\/ACAM.21457","article-title":"Thiol\/disulfide homeostasis as a new oxidative stress marker in patients with neonatal transient tachypnea.","volume":"14","author":"Erdal","year":"2023","journal-title":"Ann Clin Anal Med"},{"key":"R14-20250328","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574886315666200128095958","article-title":"Treatment of psoriasis: a comprehensive review of entire therapies.","volume":"15","author":"Bakshi","year":"2020","journal-title":"Curr Drug Saf"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3S","key":"R16-20250328","first-page":"10","article-title":"Current guidelines for psoriasis treatment: a work in progress.","volume":"101","author":"Golbari","year":"2018","journal-title":"Cutis"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4328\/ACAM.21799","article-title":"Are pan-immune inflammation value, systemic inflammatory response index clinically useful to predict in patients with chronic spontaneous urticaria?","volume":"14","author":"Erdal","year":"2023","journal-title":"Ann Clin Anal Med"},{"key":"R18-20250328","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4328\/ACAM.21626","article-title":"Are pan-immune-inflammation value, systemic inflammatory response index and other hematologic inflammatory indexes clinically useful to predict first-trimester pregnancy loss?","volume":"14","author":"Genc","year":"2023","journal-title":"Ann Clin Anal Med"},{"key":"R19-20250328","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4328\/ACAM.21807","article-title":"Is there a relationship between systemic immune-inflammatory indices and asthma?","volume":"14","author":"Gunaydin","year":"2023","journal-title":"Ann Clin Anal Med"},{"key":"R20-20250328","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4328\/ACAM.21657","article-title":"Can pan-immune inflammation value and systemic inflammatory response index be used clinically to predict inflammation in patients with cataract?","volume":"14","author":"Akbulut Yagci","year":"2023","journal-title":"Ann Clin Anal Med"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","article-title":"Systemic immune-inflammation index for predicting prognosis of colorectal cancer.","volume":"23","author":"Chen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician\u2019s global assessment.","volume":"51","author":"Langley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250328","doi-asserted-by":"crossref","first-page":"88","DOI":"10.55563\/clinexprheumatol\/m46d0v","article-title":"Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.","volume":"39","author":"Lee","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"364","DOI":"10.36472\/msd.v10i6.946","article-title":"Pan-immune-inflammation value in FMF patients.","volume":"10","author":"Uluta\u015f","year":"2023","journal-title":"Med Sci Discov"},{"key":"R25-20250328","doi-asserted-by":"crossref","first-page":"e37230","DOI":"10.1097\/MD.0000000000037230","article-title":"The relationship between disease activity with pan-immune-inflammatory value and systemic immune-inflammation index in rheumatoid arthritis.","volume":"103","author":"Ba\u015faran","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R26-20250328","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/etm.2022.11124","article-title":"Update on the etiopathogenesis of psoriasis (Review).","volume":"23","author":"Branisteanu","year":"2022","journal-title":"Exp Ther Med"},{"key":"R27-20250328","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective.","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"R28-20250328","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1389202923666220527111037","article-title":"Etiopathogenesis of psoriasis from genetic perspective: an updated review.","volume":"23","author":"Babaie","year":"2022","journal-title":"Curr Genomics"},{"key":"R29-20250328","first-page":"97","article-title":"Current developments in the immunology of psoriasis.","volume":"93","author":"Gr\u00e4n","year":"2020","journal-title":"Yale J Biol Med"},{"key":"R30-20250328","doi-asserted-by":"crossref","first-page":"1305701","DOI":"10.3389\/fimmu.2024.1305701","article-title":"Association between systemic immune-inflammation index and psoriasis: a population-based study.","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"R31-20250328","first-page":"352","article-title":"Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis.","volume":"46","author":"Yorulmaz","year":"2020","journal-title":"Curr Health Sci J"},{"key":"R32-20250328","doi-asserted-by":"crossref","first-page":"e14101","DOI":"10.1111\/ijcp.14101","article-title":"The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis.","volume":"75","author":"Dincer Rota","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R33-20250328","doi-asserted-by":"crossref","first-page":"773","DOI":"10.29271\/jcpsp.2022.06.773","article-title":"Systemic immune inflammation index as a reliable disease activity marker in psoriatic arthritis.","volume":"32","author":"Kelesoglu Dincer","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"R34-20250328","first-page":"291","article-title":"Systemic immune-inflammation index as a biomarker of psoriasis severity.","volume":"5","author":"Melikoglu","year":"2023","journal-title":"Arch Basic Clin Res"},{"key":"R35-20250328","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/ijd.16744","article-title":"The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa.","volume":"62","author":"\u00d6ks\u00fcm Solak","year":"2023","journal-title":"Int J Dermatol"},{"key":"R36-20250328","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1111\/jdv.18895","article-title":"Systemic immune-inflammation biomarkers in psoriasis patients under interleukin 17A-inhibitor treatment.","volume":"37","author":"Gambichler","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:22:36Z","timestamp":1743362556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041715","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}